Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -6.25% is 115% below its 5-year average of 41.07%, near the high end of its 5-year range (-627.39%–92.60%).
92.80% above its 12-month average of -86.86%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2.31%.
GROSS MARGIN
-6.25%
GROSS MARGIN AVG TTM
-86.86%
GROSS MARGIN AVG 3Y
50.37%
GROSS MARGIN AVG 5Y
41.07%
GROSS MARGIN AVG 10Y
35.51%
GROSS MARGIN AVG 15Y
33.24%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+92.80%
CURRENT VS 3Y AVG
-112.41%
CURRENT VS 5Y AVG
-115.22%
CURRENT VS 10Y AVG
-117.60%
CURRENT VS 15Y AVG
-118.80%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.76%
median of 627 covered companies
CURRENT VS SECTOR MEDIAN
-114.97%
vs the sector median at left
Market Cap
$3.49M
Gross Margin
79.65%
TTM Avg
78.98%
3Y Avg
76.82%
5Y Avg
80.07%
Market Cap
$3.32M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
50.00%
Market Cap
$3.27M
Gross Margin
36.10%
TTM Avg
40.19%
3Y Avg
41.87%
5Y Avg
47.28%
Market Cap
$3.25M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evogene Ltd. (EVGN) | $3.46M | -6.25% | -86.86% | 50.37% | 41.07% |
| Moolec Science S.A. (MLEC)vs › | $3.46M | 34.17% | 21.29% | 6.69% | 5.35% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nexalin Technology, Inc. (NXL)vs › | $3.49M | 79.65% | 78.98% | 76.82% | 80.07% |
| Eocene Ltd. (EOCN)vs › | $3.47M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.32M | 0.00% | 0.00% | 25.00% | 50.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.27M | 36.10% | 40.19% | 41.87% | 47.28% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| MBody AI Ltd. (MBAI)vs › | $3.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.00M | 0.00% | 41.76% | -40.89% | -27.26% |
Gross Margin
-6.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -2.31% |
| 2026-03-31 | 61.08% |
| 2025-12-31 | -627.39% |
| 2025-09-30 | 49.68% |
| 2025-06-30 | 84.62% |
| 2025-03-31 | 33.96% |
| 2024-12-31 | 53.13% |
| 2024-09-30 | 40.11% |
| 2024-06-30 | 44.46% |
| 2024-03-31 | 92.60% |
| 2023-12-31 | 31.14% |
| 2023-09-30 | 86.43% |
| 2023-06-30 | 29.51% |
| 2023-03-31 | 49.77% |
| 2022-12-31 | 44.85% |
| 2022-09-30 | 74.25% |
| 2022-06-30 | 16.03% |
| 2022-03-31 | 31.22% |
| 2021-12-31 | 14.15% |
| 2021-09-30 | 33.11% |
| 2021-06-30 | 5.19% |
| 2021-03-31 | 18.62% |
| 2020-12-31 | 1.42% |
| 2020-09-30 | 76.27% |
| 2020-06-30 | 61.74% |
| 2020-03-31 | 48.00% |
| 2019-12-31 | 30.17% |
| 2019-09-30 | 16.49% |
| 2019-06-30 | 47.40% |
| 2019-03-31 | 79.60% |
| 2018-12-31 | 1.26% |
| 2018-09-30 | 24.80% |
| 2018-06-30 | 30.08% |
| 2018-03-31 | 22.40% |
| 2017-12-31 | 13.62% |
| 2017-09-30 | 27.01% |
| 2017-06-30 | 13.58% |
| 2017-03-31 | 10.26% |
| 2016-12-31 | 4.15% |
| 2016-09-30 | 7.68% |
| 2016-06-30 | 12.89% |
| 2016-03-31 | 24.85% |
| 2015-12-31 | 18.55% |
| 2015-09-30 | 24.84% |
| 2015-06-30 | 27.26% |
| 2015-03-31 | 32.25% |
| 2014-12-31 | 34.51% |
| 2014-09-30 | 26.14% |
| 2014-06-30 | 37.01% |
| 2014-03-31 | 33.55% |
| 2013-12-31 | 35.58% |
| 2013-09-30 | 38.99% |
| 2013-06-30 | 43.08% |
| 2013-03-31 | 51.69% |
| 2012-12-31 | 45.02% |
| 2012-09-30 | 39.00% |
| 2012-06-30 | 41.18% |
